Table 4.

Postoperative course of all patients, depending on FFP-classification*

	FFP type I–IV	FFP type I	FFP type II	FFP type III	FFP type IV	p value
All patients (n)	140	2	52	18	68
Open procedures (n; %)	41 (29.3)	1	6 (11.5)	12 (66.7)	22 (32.4)	< 0.001
Median LoS (days)	18	9.5	17	21	18	0.65
Minimum (days)	3	9	3	10	6
Maximum (days)	92	10	92	56	68
IQR (days)	14–25	9.25–9.75	14.8–25.0	14.5–24.5	13–25.5
Median postoperative LoS (days)	12	6	12	14.5	12	0.3
Minimum (days)	2	2	3	8	3
Maximum (days)	74	10	74	49	51
IQR (days)	9–17	4–8	9–15	11.25–17.75	9–18
Patients with general in-hospital complications (n, %)	51 (36.4)	0	14 (26.9)	12 (66.7)	24 (35.3)	0.01
Urinary tract infection (UTI) (n, %)	37 (26.4)	0	10 (19.2)	9 (50.0)	18 (26.5)	0.046
Pneumonia (n, %)	7 (5.0)	0	3 (5.8)	1 (5.6)	3 (4.4)	1
Cardiovascular (n, %)	4 (2.9)	0	3 (5.8)	0 (0.0)	1 (1.5)	0.35
Bedsore (without skin necrosis) (n, %)	11 (7.9)	0	5 (9.6)	3 (16.7)	3 (4.4)	0.13
Thrombosis (n, %)	4 (2.9)	0	2 (3.8)	0 (0.0)	2 (2.9)	1
Lung embolism (n, %)	2 (1.4)	0	1 (1.9)	1 (5.5)	0 (0.0)	0.12
Patients with surgery-related complications (n, %)	37 (26.4)	1	11 (21.2)	8 (44.4)	17 (25)	0.15
Hematoma (n, %)	10 (7.1)	0	3 (5.8)	1 (5.6)	6 (8.8)	0.90
Infection (n, %)	7 (5)	0	3 (5.8)	2 (11.1)	2 (2.9)	0.29
Implant malposition (n, %)	2 (1.4)	0	2 (3.8)	0	0	0.38
Implant loosening (n, %)	13 (9.3)	0	4 (7.7)	2 (11.1)	7 (10.3)	0.85
Implant failure (n, %)	3 (2.1)	0	1 (1.9)	1 (5.6)	1 (1.5)	0.51
Dysesthesia–paresis (n, %)	7 (5)	0	2 (3.8)	3 (16.7)	2 (2.9)	0.08
Suprapubic hernia (n, %)	2 (1.4)	1	1 (1.9)	0	0	0.51
Patients with surgical revision (%)	25 (17.9)	1	9 (17.3)	4 (22.2)	11 (16.2)	0.78

P values below 0.05 are shown in bold

LoS Length of hospital Stay

*Due to the low number of patients with FFP type I, % is not calculated